SNY
Sanofi Healthcare - Pharmaceuticals Investor Relations →
Sanofi (SNY) closed at $46.08 as of 2026-05-01, trading 1.2% below its 200-week moving average of $46.66. This places SNY in the below line zone. The stock is currently moving closer to the line, down from 0.3% last week. The 14-week RSI sits at 47, indicating neutral momentum.
Trading volume is running at 0.8x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.84 ratio) is neutral — neither side is clearly dominating.
Over the past 1195 weeks of data, SNY has crossed below its 200-week moving average 20 times. On average, these episodes lasted 12 weeks. Historically, investors who bought SNY at the start of these episodes saw an average one-year return of +11.3%.
With a market cap of $110.4 billion, SNY is a large-cap stock. The company generates a free cash flow yield of 15.1%, which is notably high. Return on equity stands at 6.6%. The stock trades at 1.3x book value.
Over the past 22.9 years, a hypothetical investment of $100 in SNY would have grown to $349, compared to $1122 for the S&P 500. SNY has returned 5.6% annualized vs 11.1% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -5% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: SNY vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After SNY Crosses Below the Line?
Across 18 historical episodes, buying SNY when it crossed below its 200-week moving average produced an average return of +9.0% after 12 months (median +13.0%), compared to +13.5% for the S&P 500 over the same periods. 80% of those episodes were profitable after one year. After 24 months, the average return was +22.1% vs +34.5% for the index.
Each line shows $100 invested at the moment SNY crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
SNY has crossed below its 200-week MA 20 times with an average 1-year return of +11.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 2003 | Sep 2003 | 5 | 6.2% | +21.2% | +277.3% |
| Jan 2008 | Sep 2009 | 86 | 35.7% | -21.7% | +139.6% |
| Feb 2010 | Feb 2010 | 1 | 1.3% | +2.1% | +148.1% |
| Apr 2010 | Sep 2010 | 21 | 17.2% | +22.2% | +158.3% |
| Nov 2010 | Jan 2011 | 7 | 2.3% | +3.5% | +159.9% |
| Nov 2015 | Mar 2017 | 71 | 16.0% | -0.5% | +59.5% |
| Apr 2017 | Apr 2017 | 1 | 0.8% | -6.4% | +49.3% |
| Dec 2017 | Jan 2018 | 4 | 1.5% | +5.6% | +47.4% |
| Jan 2018 | Jul 2018 | 22 | 10.9% | +5.2% | +47.4% |
| Mar 2020 | Mar 2020 | 1 | 7.1% | +36.2% | +53.1% |
| Aug 2022 | Nov 2022 | 15 | 14.9% | +25.2% | +17.3% |
| Oct 2023 | Nov 2023 | 3 | 6.9% | +31.3% | +16.3% |
| Dec 2023 | Dec 2023 | 1 | 0.3% | +9.1% | +8.3% |
| Feb 2024 | Feb 2024 | 2 | 1.6% | +19.6% | +7.9% |
| Apr 2024 | Apr 2024 | 2 | 2.5% | +16.9% | +9.2% |
| Sep 2025 | Sep 2025 | 1 | 1.3% | N/A | +1.2% |
| Jan 2026 | Jan 2026 | 1 | 0.1% | N/A | -1.1% |
| Feb 2026 | Feb 2026 | 1 | 1.3% | N/A | +0.2% |
| Mar 2026 | Mar 2026 | 3 | 6.5% | N/A | +3.4% |
| Apr 2026 | Ongoing | 1+ | 1.2% | Ongoing | N/A |
| Average | 12 | — | +11.3% | — |
Frequently Asked Questions
Is SNY below its 200-week moving average?
Yes. As of 2026-05-01, Sanofi (SNY) is trading 1.2% below its 200-week moving average of $46.66. The current price is $46.08.
What is SNY's 200-week moving average price?
Sanofi's 200-week moving average is $46.66 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when SNY drops below its 200-week moving average?
SNY has crossed below its 200-week moving average 20 times in our data. On average, buying at that moment produced a one-year return of +11.3%. These dips have historically been decent entry points. These episodes lasted 12 weeks on average.
Is SNY a good value right now?
Here's what our data says about SNY as of 2026-05-01: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 47. Free cash flow yield is 15.1%. Return on equity is 6.6%. Price-to-book is 1.3x. This is not a buy or sell recommendation — always do your own research.
How does SNY compare to the S&P 500?
Over the past 22.9 years, $100 invested in SNY would have grown to $349, compared to $1122 for the S&P 500. That's 5.6% annualized vs 11.1% for the index. SNY has underperformed the broader market over this period.
Does SNY pay a dividend?
Yes. Sanofi currently pays a dividend yield of 525.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01